Trial of BMS-986012 in Combination With Platinum and Etoposide

Clinical trial NCT02815592 · COMPLETED

Trial details

NCT number: NCT02815592
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2016-11-28
Primary completion: 2019-12-15
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.